SCHEMBL20150346

SCHEMBL20150346

Cc1ccc(-c2ccc3c4ccc(-c5ccc(C)cc5)cc4n(-c4cc(C#N)ccc4-c4nc(C)nc(C)n4)c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.36
GRM2 Q14416 1/20 0.35
MAPKAPK2 P49137 1/20 0.35
FLT3 P36888 6/20 0.34
ITK Q08881 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP2A6 P11509 1/20 0.33
KDM1A O60341 4/20 0.33
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
CSNK1A1 P48729 1/20 0.32
CSNK1D P48730 1/20 0.32
GSK3B P49841 1/20 0.32
CSNK1G2 P78368 1/20 0.32
PTGER4 P35408 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20114562 0.95 CHEK1 (0.40) CHEK1GRM2FLT3CYP11B1CYP11B2
SCHEMBL20114689 0.95 PTGER4 (0.36) CHEK1GRM2MAPKAPK2FLT3PTGER4
SCHEMBL20114543 0.92 CHEK1 (0.36) CHEK1ALDH1A1CYP11B1CYP11B2CSNK1A1
SCHEMBL20150354 0.92 CHEK1 (0.34) CHEK1GRM2FLT3ITKCYP11B1
SCHEMBL20150372 0.92 CYP11B2 (0.34) CHEK1GRM2ITKALDH1A1CYP11B1
SCHEMBL20115142 0.91 CHEK1 (0.34) CHEK1CYP11B1CYP11B2PTGER4
SCHEMBL22268469 0.91 CHEK1 (0.36) CHEK1GRM2MAPKAPK2FLT3ITK
SCHEMBL20150391 0.91 CHEK1 (0.36) CHEK1GRM2MAPKAPK2FLT3ITK
SCHEMBL20114547 0.91 MAPKAPK2 (0.37) CHEK1GRM2MAPKAPK2FLT3ITK
SCHEMBL20114637 0.91 ITK (0.38) GRM2ITKALDH1A1CYP2A6CSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 CHEK1 2795/4885GRM2 1828/4885MAPKAPK2 3348/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 CHEK1 2795/4885GRM2 1828/4885MAPKAPK2 3348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.